HOME

SUPERBRANCHE : Dentritic Nanoparticles

supporting early stage diagnosis and targeted therapy

WATCH THE VIDEO ABOUT OUR INNOVATIVE TECHNOLOGY

Lire la vidéo

SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer.
We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand. We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size.

INNOVATION

Our modular technology platform presents both therapeutic and diagnosis applications.
It consists in a magnetic nanoparticle coated by a tailor made branched architecture.
Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously,
thus helping to the early detection and treatment of metastases.
The main advantage of the SUPERBRANCHE technology stem from
our specific  processes and synthesis know-how which are at the heart of our innovations.”

ABOUT SUPERBRANCHE

Superbranche is a spin-off company from a CNRS – University of Strasbourg – ECPM mixed research unit which technology of dendronized magnetic nanoparticles has been validated by several hospitals
0
Years of Research
0
Proof of Concept
0
Patents

STAY TUNED

FOLLOW US ON SOCIAL NETWORKS

SuperBranche is part of the « 100 startups to invest in in 2021 » selection of challenges Magazine
SuperBranche is proud to provide the THERAGET consortium
SuperBranche ouvre son capital